RBM8A and Alzheimer disease: We found that the low expression of RBM8A may lead to the decrease of the components of key complexes (FIP200, Beclin 1, NRBF2, VPS15 and ATG12) in autophagy-pathway, which are associated with autophagy disorder and may contribute to the risk of AD.